G1 Therapeutics slips on J.P.Morgan cut to 'underweight'

G1 Therapeutics

06/10/2023 12:31

** Drugmaker G1 Therapeutics'  GTHX.O  shares fall 4.7% to
$1.21 premarket
    ** J.P.Morgan downgrades stock to "underweight" from
"neutral"
        ** Says they anticipate a Q3 sales miss for co's blood
disorder drug Cosela 
    ** Adds that co's pipeline has more to prove and has faced
too many setbacks
    ** 6 of 7 brokerages rate the stock "buy" or higher, and 1
"sell" or lower; their median PT is $8 - LSEG data
    ** Up to last close, stock down 76.6% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))